Personalized Medicine
Cancer treatment is not a one-size-fits-all series of treatments or procedures. Two similar patients with the same type of cancer may have very different outcomes. This is because two cancers that may look very similar under the microscope often have unique molecular characteristics. Furthermore, every individual is genetically distinct. One patient may not have any side effects from therapy while another may experience side effects. Molecular testing can help tell us the right dose of the right drug for the right cancer.
At Willamette Valley Cancer Institute and Research Center (WVCI), we believe in treating each patient on a case-by-case basis, focusing on the unique attributes of the individual, as well as the specific characteristics of the disease. By fully understanding both patients and their diseases, we can more effectively combat the cancer.
Targeted Therapy
With some types of cancer, we know exactly what is causing the disease and what can be done to stop it. In some cases, targeted therapy can have dramatic results. By looking for biologic markers associated with prognosis and treatment response, WVCI doctors are able to increase the effectiveness and reduce the side effects of certain cancer fighting therapies.
Targeted therapy is not an option for every cancer, but more and more patients are benefitting from these powerful tools in the WVCI cancer-fighting arsenal.
Tumor Variation
Biologic changes in cancer cells can help determine vulnerability to specific types of therapies. WVCI physicians routinely test for specific mutations that can reveal the best treatment options in common diseases such as cancers of the breast, lung, colon, prostate, blood and others.
Patient Variation
Tumors aren't the only variable. The interaction between individuals and their therapies may determine whether treatments will be successful. By measuring levels of absorption, drug metabolism or interaction with other drugs, WVCI doctors can determine what medications and dosages are right for each patient.
